Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 29;17(1):299.
doi: 10.1186/s13098-025-01882-7.

Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide cohort study

Jintao Chen  1 , Liying Yan  2 , Lei He  1 , Weixue Wang  3
Affiliations

Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide cohort study

Jintao Chen et al. Diabetol Metab Syndr. .

Abstract

Background: Cardiovascular-kidney-metabolic (CKM) syndrome highlights the complex interplay between metabolic disturbances, kidney disease, and cardiovascular conditions. In this process, inflammation and insulin resistance play pivotal roles. The C-reactive protein-triglyceride-glucose index (CTI), a novel biomarker of insulin resistance and inflammation, remains unestablished for predicting cardiovascular disease (CVD) risk in CKM syndrome stages 0-3.

Methods: This study analyzed data from the China Health and Retirement Longitudinal Study. The outcome measure was self-reported CVD. The exposure measure, CTI, was calculated as: 0.412*Ln(C-reactive protein [mg/L]) + Ln[fasting triglycerides (mg/dL) * fasting glucose (mg/dL)/2]. Cumulative CTI was calculated as: (CTI 2012 + CTI 2015)/2 *Time (2015-2012). K-means clustering was used to categorize CTI fluctuations into four distinct clusters. Cox proportional hazards models were employed to examine the relationship between CTI and new-onset CVD risk in individuals across different CKM syndrome stages. The form of this relationship was further analyzed using restricted cubic splines. Additionally, the predictive ability was assessed using the receiver operating characteristic curve.

Results: This study included 5111 individuals with CKM syndrome stages 0-3, with a mean age of 61.78 ± 8.68 years, of which 45.7%(2337) were male. During the follow-up period, 555 new cases of CVD were observed (10.9%). Our findings demonstrated a significant positive linear relationship between CTI and the risk of CVD in individuals with CKM syndrome stages 0-3. In model 3, each 1.0-SD increase in cumulative CTI was associated with a 21% increase in CVD risk (adjusted hazard ratio, aHR = 1.21 [95% CI: 1.10-1.33]). Similarly, each 1.0-SD increase in baseline CTI was associated with an 18% increase in CVD risk (aHR = 1.18 [95% CI: 1.07-1.30]). Additionally, Receiver operating characteristic analysis revealed that cumulative CTI had a better predictive performance for CVD risk compared to the cumulative TyG index (AUC: 0.596 vs 0.560, DeLong test p < 0.05).

Conclusions: Higher CTI levels in individuals with CKM syndrome stages 0-3 are significantly associated with increased CVD risk. Longitudinal monitoring of CTI changes over time can help early identification of high CVD risk in this population, and its predictive value is significantly superior to that of the TyG index.

Keywords: C-reactive protein-triglyceride-glucose index; Cardiovascular diseases; Cardiovascular kidney metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study protocol was approved by the Ethics Review Committee of Peking University (IRB00001052-11015), and all participants provided written informed consent. Consent for publication: All authors agree to take full responsibility for the completeness and accuracy of the manuscript and have reviewed and approved the final published version. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Clustering of changes in CTI from 2012 to 2015
Fig. 2
Fig. 2
RCS analysis of the association between cumulative CTI and baseline CTI and CVD risk in the CKM syndrome stages 0–3, the CKM syndrome stages 0–2, and the CKM syndrome stage 3
Fig. 3
Fig. 3
Subgroup analysis of the association between cumulative CTI and baseline CTI and CVD risk in individuals with CKM syndrome stage 0–3 in model 3
Fig. 4
Fig. 4
Comparison of the Predictive Performance of CTI and TyG Index for Future CVD Risk in Individuals with CKM Syndrome stages 0–3
See this image and copyright information in PMC

References

    1. Ndumele CE, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606–35. 10.1161/CIR.0000000000001184. - PubMed
    1. Khan SS, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982–2004. 10.1161/CIR.0000000000001191. - PubMed
    1. Chen Y, et al. Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):147. 10.1186/s12933-025-02692-x. - PMC - PubMed
    1. Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195. 10.1186/s12933-023-01937-x. - PMC - PubMed
    1. Rana MN, Neeland IJ. Adipose tissue inflammation and cardiovascular disease: an update. Curr Diab Rep. 2022;22(1):27–37. 10.1007/s11892-021-01446-9. - PubMed

LinkOut - more resources